Video

Overcome Trust Issues To Solve The Patient Diversity Problem

Source: Clinical Leader
20_11_CLL_PatientDiversity_1920x1080_Clip3

Patient diversity remains a problem in clinical trials. Although FDA-approved medicines serve a diverse population of Americans, participation in clinical trials remains predominantly white and male. 

In this webinar segment, Robin Weinick, SVP & Managing Director, Americas and Global Program Officer for DIA, discusses the role played by our healthcare system. Americans in different states, cities, and communities do not have access to the same levels of healthcare. That discrepancy can lead to a distrust of physicians, insurers, health centers, and drug developers. Sponsors must overcome trust issues if they are to solve the patient diversity problem. Weinick discusses the lack of trust in the process, the Tuskegee experiments, and why communication is critical to overcoming these trust issues.

VIEW THE VIDEO!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: